🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/07/2019 | 67,09 | 67,71 | 66,31 | 67,43 | +0,94% | 2,08% | 389.689 |
| 25/07/2019 | 68,75 | 69,04 | 66,65 | 66,80 | -3,10% | 3,48% | 578.843 |
| 24/07/2019 | 68,70 | 69,91 | 68,18 | 68,93 | +0,39% | 2,52% | 579.485 |
| 23/07/2019 | 70,24 | 70,58 | 68,41 | 68,67 | -1,51% | 3,09% | 614.270 |
| 22/07/2019 | 71,26 | 72,04 | 69,56 | 69,72 | -1,58% | 3,48% | 495.968 |
| 19/07/2019 | 71,71 | 72,68 | 70,82 | 70,84 | -1,16% | 2,58% | 332.783 |
| 18/07/2019 | 69,97 | 72,08 | 69,92 | 71,67 | +2,21% | 3,08% | 461.985 |
| 17/07/2019 | 72,94 | 72,94 | 69,97 | 70,12 | -3,87% | 4,07% | 536.204 |
| 16/07/2019 | 72,68 | 74,12 | 72,30 | 72,94 | +0,33% | 2,51% | 297.837 |
| 15/07/2019 | 72,73 | 73,78 | 71,75 | 72,69 | +0,40% | 2,80% | 488.594 |
| 12/07/2019 | 71,62 | 73,18 | 70,73 | 72,40 | +1,29% | 3,41% | 396.101 |
| 11/07/2019 | 75,04 | 75,13 | 70,78 | 71,48 | -4,64% | 5,79% | 579.965 |
| 10/07/2019 | 74,15 | 75,33 | 73,40 | 74,96 | +2,72% | 2,61% | 468.557 |
| 09/07/2019 | 72,51 | 74,24 | 72,51 | 72,98 | +0,18% | 2,37% | 422.871 |
| 08/07/2019 | 72,68 | 74,05 | 71,88 | 72,84 | -0,17% | 2,98% | 577.401 |
| 05/07/2019 | 72,73 | 73,61 | 72,32 | 72,97 | -0,17% | 1,77% | 419.024 |
| 03/07/2019 | 71,90 | 73,44 | 70,68 | 73,09 | +2,47% | 3,84% | 555.600 |
| 02/07/2019 | 71,45 | 72,20 | 70,81 | 71,34 | -0,44% | 1,94% | 481.221 |
| 01/07/2019 | 72,51 | 72,51 | 70,71 | 71,65 | +0,61% | 2,49% | 566.821 |
| 28/06/2019 | 71,30 | 72,18 | 70,71 | 71,21 | +0,10% | 2,06% | 1.540.162 |
| 27/06/2019 | 70,05 | 71,32 | 69,54 | 71,14 | +2,46% | 2,54% | 533.959 |
| 26/06/2019 | 68,34 | 70,49 | 68,34 | 69,43 | +1,60% | 3,15% | 491.320 |
| 25/06/2019 | 68,70 | 70,16 | 68,21 | 68,34 | -0,30% | 2,83% | 450.283 |
| 24/06/2019 | 69,82 | 70,18 | 68,44 | 68,55 | -1,80% | 2,49% | 470.000 |
| 21/06/2019 | 69,76 | 70,66 | 68,26 | 69,80 | -0,36% | 3,43% | 1.106.070 |
| 20/06/2019 | 72,08 | 72,11 | 70,03 | 70,05 | -1,72% | 2,90% | 504.945 |
| 19/06/2019 | 71,63 | 72,91 | 70,84 | 71,28 | -0,03% | 2,89% | 537.486 |
| 18/06/2019 | 70,26 | 71,74 | 68,67 | 71,30 | +2,61% | 4,37% | 523.059 |
| 17/06/2019 | 67,50 | 69,56 | 66,72 | 69,48 | +3,70% | 4,20% | 584.614 |
| 14/06/2019 | 71,00 | 71,00 | 66,85 | 67,01 | -5,60% | 5,84% | 638.956 |